ARBs Do NOT Cause Dry Cough or Wheeze
ARBs have a cough incidence similar to placebo and are specifically recommended as the alternative for patients who develop ACE inhibitor-induced cough. 1
Key Evidence from Guidelines
The ACCP evidence-based guidelines (2006) provide Grade A recommendations (good quality evidence, substantial benefit) stating that ARBs have a cough incidence similar to control drugs 1. This is fundamentally different from ACE inhibitors, which cause cough in 5-35% of patients through bradykinin and substance P accumulation 1.
Mechanism Explains the Difference
ARBs work by blocking angiotensin II receptors directly, without inhibiting ACE enzyme activity. This means they don't cause accumulation of bradykinin and substance P in the respiratory tract—the exact mechanism responsible for ACE inhibitor cough 1. The first ARB (losartan) demonstrated cough rates equivalent to hydrochlorothiazide, even in patients with documented ACE inhibitor-induced cough 1.
Clinical Application
When a patient develops persistent dry cough on an ACE inhibitor:
- Switch to an ARB as first-line alternative (Grade A recommendation) 1
- The cough typically resolves within 1-4 weeks of stopping the ACE inhibitor 1
- ARBs provide equivalent cardiovascular protection without the cough side effect 2
Important Caveats
Rare case reports exist of ARB-associated cough 3, but these are exceptional outliers. One case report described losartan-induced cough that paradoxically resolved with enalapril 3—this represents an idiosyncratic reaction, not a class effect.
Cross-reactivity with angioedema is possible but uncommon. While ARBs don't cause angioedema through the same mechanism as ACE inhibitors, extreme caution is warranted when substituting an ARB in patients who developed angioedema on an ACE inhibitor 4, 5.
Wheeze Specifically
Neither the guidelines nor high-quality studies identify wheeze as an ARB side effect. Wheeze associated with ACE inhibitors is also uncommon—the typical presentation is a dry, tickling cough without bronchospasm 1. If wheeze is present, consider alternative diagnoses (asthma, heart failure, other pulmonary conditions) rather than attributing it to the ARB.
Bottom Line for Practice
Do not avoid ARBs due to cough concerns. They are the evidence-based alternative specifically because they don't cause cough 1. Recent network meta-analyses confirm ARBs have significantly lower cough incidence than ACE inhibitors (RR 3.2 favoring ARBs) 6, with rates comparable to placebo 7, 2.